netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Release found 24 matches

Formulary items 17 matches
Sub Section Title / notes 2  matches
   
Open monograph to display formulary status BNF Category
  Budesonide
(Oral Preparations)
Gastro-intestinal system - Corticosteroids - 01.05.02
  Controlled Drug Buprenorphine  (Buvidal®) Central nervous system - Opioid substitution therapy - 04.10.03
  Cabotegravir  (Vocabria®) Infections - Other antiretrovirals - 05.03.01
  Exenatide Endocrine system - GLP1 agonists - 06.01.02.03
  Guanfacine  (Intuniv®) Central nervous system - CNS stimulants and other drugs used for attention deficit hyperactivity disorder - 04.04
  Indapamide 2.5mg tablets Cardiovascular system - Thiazides and related diuretics - 02.02.01
  Isosorbide Mononitrate 10mg, 20mg and 40mg tablets, and 60mg MR tablets Cardiovascular system - Nitrates - 02.06.01
  Liposomal Bupivacaine  (Exparel® ) Anaesthesia - Bupivacaine - 15.02
  Magnesium chloride Nutrition and blood - Magnesium - 09.05.01.03
  Melatonin Central nervous system - Hypnotics - 04.01.01
  Controlled Drug Methylphenidate Central nervous system - CNS stimulants and other drugs used for attention deficit hyperactivity disorder - 04.04
  Nifedipine Cardiovascular system - Calcium-channel blockers - 02.06.02
  Oxybutynin Obstetrics, Gynaecology, and urinary-tract disorders - Urinary incontinence - 07.04.02
  Oxybutynin Hydrochloride - patch Obstetrics, Gynaecology, and urinary-tract disorders - Urinary incontinence - 07.04.02
  Controlled Drug Oxycodone Central nervous system - Opioid analgesics - 04.07.02
  Quetiapine Central nervous system - Second Generation Antipsychotic Drugs - 04.02.01
  Controlled Drug Tramadol Central nervous system - Opioid analgesics - 04.07.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Sep 2022): Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations (07.04.02)
link in drug section NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (02.09)
link in drug section NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (02.09)
link in drug section NICE TA937: Targeted-release budesonide for treating primary IgA nephropathy (01.05.02)
link in drug section NTAG - Buprenorphine prolonged release injection for opioid dependence (04.10.03)

SubSection Titles / notes  
Acetylcholine-Release enhancers - (10.02.01)
Theophylline - (03.01.03)

 

netFormulary